click below
click below
Normal Size Small Size show me how
P JESSIE PHARM CH 2
PHARMACOLOGY CHAPTER 2
| Question | Answer |
|---|---|
| diuretic | an agent that promotes urine |
| emesis | drug for vomiting |
| analgesic | class of drugs that suppresses pain |
| antiinfective | general term for class of drugs to treat any pathogen |
| antineoplastics | class of drugs that is toxic to dividing cells and is used to treat cancer |
| antiseptics | class of drugs that inhibits bacterial growth, but does not destroy bacteria |
| antiviral | class of drugs used to treat viral infections |
| cardiovascular | antihypertensive, diuretics, beta blocker |
| central nervous system (CNS) | antianxiety, antidepressants, stimulants |
| endocrine & metabolic | estrogens, tyroid, corticosteroids |
| gastrointestinal | antidiarrheals, laxatives, digest aids |
| hematologics | anticoagulants, hemostatics |
| neuromuscular | anticonvulsant, skeletal muscle relaxants |
| nonsteroidal anti-inflammatory drugs (NSAID) | ibuprofen |
| nutritional | minerals, vitamins, electrolytes |
| proton pump inhibitor | omeprazole, lansoprazole |
| respiratory | antiasthmatics, antihistamines, decongestants |
| topical | ophthalmic, otic, intrarectal steroids |
| pregnancy categorie A | No known studies proving risk or harm to fetushave been performed. |
| pregnancy categorie B | No known animal studies show risk. if animal studies have shown risk, no syudies in women confirm risk. |
| pregnancy categorie C | Animal studies show risk, no study in women. |
| pregnancy categorie D | Drugs may cause harm, but may provide benefit if no other drug is available or a life theatening situation is present. |
| pregnancy categorie X | High risk to women and fetus. |
| teratogenic | Tends to produce anomalies of formation. |
| Controlled Substances act of 1970 | was designed to regulate how pharmaceuticals are handled, dispensed and directed by physicians. |
| class 1 | schedule 1 |
| class 2 | schedule 2 |
| class 3 | schedule 3 |
| class 4 | schedule 4 |
| class 5 | schedule 5 |
| routes of administration | oral, buccal & sublingual absorption, topical, rectal, vaginal, inhalation nasogastral, parenteral administrations |
| oral administration | by mouth (most common) |
| buccal & sublingual absorption | Drug get in the system by mouth, inside the cheek or under the tounge. |
| topical administration | Administered to the skin, mouth, nose, oropharynx, cornea, ear, urethra, vagina or rectum. |
| topical forms | cr, oint, gel, lot, aerosols, foams, plaster, pulv, patches, supp and spray. |
| rectal & vaginal administration | suppositories |
| inhalation administration | Involves inhaling medications. |
| inhalation forms | gas, liquid or powder |
| nasogastral administration | Bypasses oral, pouring medication into a tube through the mouth and throat into the stomach. |
| parenteral administration | Intravenous, subcutaneous or intramuscular. |
| dextrose | normal saline |
| lipophillic | No affinity for substances that contain fats |
| Drugs are classified | According to the way they affect te body. |
| Which schedule class has the highest risk of addiction? lowest? | class 1, class 5 |
| Which agency determines the classification of drugs? | FDA |
| What act was designed to regulate how pharmaceuticals are handled? | The controlled substance act of 1970. |
| Zantac is classiied as? | h2 blocker |
| The skin is? | an organ |
| name some alternative ways a patient could receive medications if not orally? | topical, injection, inhalation |
| Name a drug given pulmonary? | Albuterol |
| Three topical drugs? | bactracin, hydrocortison, eye drops |